PFWA
FOLD

Paces Ferry Wealth Advisors’s Amicus Therapeutics FOLD Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-47
Closed -$1K – 489
2020
Q3 		$1K Buy
+47
New +$685 ﹤0.01% 837

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paces Ferry Wealth Advisors's FOLD Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of Amicus Therapeutics (FOLD) in Q4 2020, closing a stake of 47 shares — an estimated $1K sold.

Paces Ferry Wealth Advisors first reported a position in FOLD in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 271 funds tracked by Wall St. Rank hold FOLD as of Q4 2020.

  • Paces Ferry Wealth Advisors reported no remaining Amicus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 47 Amicus Therapeutics shares in Q4 2020, an estimated $1K.
  • Paces Ferry Wealth Advisors first reported a position in Amicus Therapeutics in Q3 2020 and held it in 1 quarter.
  • Paces Ferry Wealth Advisors's Amicus Therapeutics position peaked at $1K in Q3 2020.
  • 271 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.